| Index | — | P/E | 52.70 | EPS (ttm) | 0.10 | Insider Own | — | Shs Outstand | 50.00M | Perf Week | 2.73% |
| Market Cap | 263.49M | Forward P/E | 26.80 | EPS next Y | 0.20 | Insider Trans | — | Shs Float | 34.46M | Perf Month | -20.51% |
| Enterprise Value | 290.49M | PEG | 0.35 | EPS next Q | 0.01 | Short Float | 11.00% | Perf Quarter | -42.66% | ||
| Income | 4.00M | P/S | 3.71 | EPS this Y | -18.52% | Short Ratio | 7.36 | Perf Half Y | -44.23% | ||
| Sales | 71.00M | P/B | 3.93 | EPS next Y | 200.60% | ROA | 3.70% | Short Interest | 3.79M | Perf YTD | -33.29% |
| Book/sh | 1.34 | P/C | 20.27 | EPS next 5Y | 151.44% | ROE | 7.92% | 52W High | 12.78 -56.89% | Perf Year | -18.42% |
| Cash/sh | 0.26 | P/FCF | — | EPS past 3/5Y | — 11.71% | ROIC | 6.18% | 52W Low | 4.10 34.39% | Perf 3Y | 80.48% |
| Dividend Est. | — | EV/EBITDA | 41.50 | Sales past 3/5Y | 58.74% 35.52% | Gross Margin | 31.44% | Volatility | 5.73% 5.43% | Perf 5Y | 9.79% |
| Dividend TTM | — | EV/Sales | 4.09 | EPS Y/Y TTM | — | Oper. Margin | 9.52% | ATR (14) | 0.34 | Perf 10Y | -54.76% |
| Dividend Ex-Date | — | Quick Ratio | 5.72 | Sales Y/Y TTM | 29.09% | Profit Margin | 6.19% | RSI (14) | 41.48 | Recom | 1.80 |
| Dividend Gr. 3/5Y | — | Current Ratio | 7.53 | EPS Q/Q | — | SMA20 | -3.66% | Beta | 1.35 | Target Price | 17.50 |
| Payout | 0.00% | Debt/Eq | 0.60 | Sales Q/Q | 0.00% | SMA50 | -13.82% | Rel Volume | 0.89 | Prev Close | 5.27 |
| Employees | 123 | LT Debt/Eq | 0.60 | Earnings | Dec 09 | SMA200 | -37.32% | Avg Volume | 479.97K | Price | 5.51 |
| IPO Date | Jan 05, 2010 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -70.82% -17.38% | Net Debt/EBITDA | 3.86 | Volume | 425,849 | Change | 4.55% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-12-26 | Reiterated | Oppenheimer | Outperform | $14 → $13 |
| Jul-16-26 | Reiterated | Raymond James | Strong Buy | $9.50 → $22 |
| Jun-05-26 | Reiterated | Roth Capital | $12 → $20 | |
| May-15-26 | Reiterated | Roth Capital | $10 → $12 | |
| May-15-26 | Reiterated | HC Wainwright & Co. | Buy | $15 |
| Feb-13-26 | Reiterated | Roth Capital | $7.00 → $10 | |
| Dec-18-25 | Initiated | Oppenheimer | Outperform | $14 |
| Dec-11-25 | Reiterated | Raymond James | $6.00 → $9.50 | |
| Dec-11-25 | Reiterated | Roth Capital | $10 → $7.00 | |
| Sep-26-24 | Initiated | Alliance Global Partners | Buy | $5.00 |
Electrovaya, Inc. is a lithium-ion battery technology and manufacturing company. engages in designing, developing, and manufacturing proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation, and other specialized applications. The firm's businesses include lithium-ion batteries to power MHEVs including forklifts and Automated Guided Vehicles, as well as accessories such as battery chargers to charge the batteries; electromotive power products for electric trucks, electric buses and other transportation applications; industrial products for energy storage; and specialty applications which require complex power solutions, including competencies in building systems for third parties. The company was founded by Sankar Das Gupta in September 1996 and is headquartered in Mississauga, Canada.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 9/30/2025 | FY 2024 9/30/2024 | FY 2023 9/30/2023 | FY 2022 9/30/2022 | FY 2021 9/30/2021 | FY 2020 9/30/2020 | FY 2019 9/30/2019 | FY 2018 9/30/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 71 | 64 | 45 | 43 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 48 | 44 | 31 | 32 | — | — | — | — | — | |
| Gross Profit | 23 | 19 | 14 | 11 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 11 | 8 | 9 | 7 | — | — | — | — | — | |
| Research and Development | 3 | 4 | 3 | 3 | — | — | — | — | — | |
| Other Operating Expense | 2 | 2 | 1 | 0 | — | — | — | — | — | |
| Operating Income | 6 | 6 | 1 | 1 | — | — | — | — | — | |
| Interest Expense | 2 | 3 | 3 | 2 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -3 | -2 | 1 | -1 | — | — | — | — | — | |
| Net Income Before Taxes | 2 | 1 | -1 | -2 | — | — | — | — | — | |
| Income Taxes | -2 | -2 | 0 | -1 | — | — | — | — | — | |
| Consolidated Net Income | 4 | 3 | -1 | -1 | — | — | — | — | — | |
| Net Income From Continuing Operations | 4 | 3 | -1 | -1 | — | — | — | — | — | |
| Net Income | 4 | 3 | -1 | -1 | — | — | — | — | — | |
| EPS (Recurring) | 0.10 | 0.09 | -0.04 | -0.04 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.10 | 0.09 | -0.04 | -0.04 | — | — | — | — | — | |
| EPS (Diluted) | 0.10 | 0.08 | -0.04 | -0.04 | — | — | — | — | — | |
| EBITDA | 7 | 5 | 3 | 1 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 55.10 | 72.18 | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 3.88 | 3.59 | 1.76 | 2.24 | — | — | — | — | — | |
| Gross Margin | 32.39 | 29.69 | 31.11 | 25.58 | — | — | — | — | — | |
| Operating Margin | 8.45 | 9.38 | 2.22 | 2.33 | — | — | — | — | — | |
| Net Margin | 5.63 | 4.69 | -2.22 | -2.33 | — | — | — | — | — | |
| Shares Outstanding | 50 | 39 | 34 | 34 | — | — | — | — | — | |
| Market Capitalization | 276 | 230 | 79 | 96 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |